Logo image of NCA

NUVEEN CALIFORNIA MUNI VAL (NCA) Stock Price, Quote, News and Overview

NYSE:NCA - New York Stock Exchange, Inc. - US67062C1071 - Currency: USD

8.4  +0.03 (+0.3%)

After market: 8.23 -0.17 (-2.02%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NCA. NCA was compared to 0 industry peers in the Unkown industry. NCA has a great financial health rating, but its profitability evaluates not so good. NCA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NCA had negative earnings in the past year.
NCA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NCA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: NCA reported negative operating cash flow in multiple years.
NCA Yearly Net Income VS EBIT VS OCF VS FCFNCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

The 3 year average ROIC (2.55%) for NCA is below the current ROIC(2.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.53%
ROE -8.57%
ROIC 2.84%
ROA(3y)-3.18%
ROA(5y)0.92%
ROE(3y)-3.19%
ROE(5y)0.93%
ROIC(3y)2.55%
ROIC(5y)2.55%
NCA Yearly ROA, ROE, ROICNCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

In the last couple of years the Operating Margin of NCA has remained more or less at the same level.
NCA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 86.87%
PM (TTM) N/A
GM 99.76%
OM growth 3Y0.26%
OM growth 5Y0%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
NCA Yearly Profit, Operating, Gross MarginsNCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200 300

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, NCA has about the same amount of shares outstanding.
NCA has more shares outstanding than it did 5 years ago.
NCA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NCA Yearly Shares OutstandingNCA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NCA Yearly Total Debt VS Total AssetsNCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 138.79 indicates that NCA is not in any danger for bankruptcy at the moment.
There is no outstanding debt for NCA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 138.79
ROIC/WACCN/A
WACCN/A
NCA Yearly LT Debt VS Equity VS FCFNCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.08 indicates that NCA has no problem at all paying its short term obligations.
A Quick Ratio of 4.08 indicates that NCA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 4.08
NCA Yearly Current Assets VS Current LiabilitesNCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1

3. Growth

3.1 Past

The earnings per share for NCA have decreased strongly by -1875.00% in the last year.
Looking at the last year, NCA shows a small growth in Revenue. The Revenue has grown by 4.20% in the last year.
The Revenue has been growing slightly by 0.61% on average over the past years.
EPS 1Y (TTM)-1875%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)4.2%
Revenue growth 3Y4.27%
Revenue growth 5Y0.61%
Sales Q2Q%7.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCA Yearly Revenue VS EstimatesNCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

NCA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCA Price Earnings VS Forward Price EarningsNCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCA Per share dataNCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

NCA has a Yearly Dividend Yield of 3.81%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.46, NCA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

NCA has been paying a dividend for at least 10 years, so it has a reliable track record.
NCA has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NCA Yearly Dividends per shareNCA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of NCA are negative and hence is the payout ratio. NCA will probably not be able to sustain this dividend level.
DP-40.28%
EPS Next 2YN/A
EPS Next 3YN/A
NCA Yearly Income VS Free CF VS DividendNCA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

NUVEEN CALIFORNIA MUNI VAL

NYSE:NCA (4/28/2025, 8:27:18 PM)

After market: 8.23 -0.17 (-2.02%)

8.4

+0.03 (+0.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)05-03 2025-05-03
Inst Owners23.14%
Inst Owner Change0.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap278.12M
Analysts81.43
Price TargetN/A
Short Float %0.23%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-40.28%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-15 2025-04-15 (0.029)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS0.38
BVpS9.21
TBVpS9.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.53%
ROE -8.57%
ROCE 3.6%
ROIC 2.84%
ROICexc 2.86%
ROICexgc 2.86%
OM 86.87%
PM (TTM) N/A
GM 99.76%
FCFM N/A
ROA(3y)-3.18%
ROA(5y)0.92%
ROE(3y)-3.19%
ROE(5y)0.93%
ROIC(3y)2.55%
ROIC(5y)2.55%
ROICexc(3y)2.56%
ROICexc(5y)2.56%
ROICexgc(3y)2.57%
ROICexgc(5y)2.56%
ROCE(3y)3.22%
ROCE(5y)3.23%
ROICexcg growth 3Y5.42%
ROICexcg growth 5Y-0.55%
ROICexc growth 3Y5.41%
ROICexc growth 5Y-0.56%
OM growth 3Y0.26%
OM growth 5Y0%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.08
Quick Ratio 4.08
Altman-Z 138.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1875%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.2%
Revenue growth 3Y4.27%
Revenue growth 5Y0.61%
Sales Q2Q%7.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.98%
EBIT growth 3Y4.54%
EBIT growth 5Y0.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1702.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1702.07%
OCF growth 3YN/A
OCF growth 5YN/A